Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes

Leuk Res. 2012 Jul;36(7):e146-8. doi: 10.1016/j.leukres.2012.03.007. Epub 2012 Apr 5.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use
  • Azacitidine / adverse effects*
  • Azacitidine / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / diagnostic imaging
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / immunology
  • Myelodysplastic Syndromes / pathology
  • Neutrophil Infiltration / drug effects
  • Neutrophil Infiltration / physiology
  • Panniculitis / chemically induced*
  • Panniculitis / diagnostic imaging
  • Panniculitis / immunology
  • Panniculitis / pathology
  • Radiography

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine